- Applied UV Inc AUVI has signed an exclusive distribution agreement with 3Sixty Biopharmaceuticals (Pty) Ltd for Airocide consumer and commercial air purification systems within the continent of Africa.
- Under the terms of the agreement, 3Sixty will purchase upfront a minimum of $3.5 million of Airocide systems over the initial one-year term of the agreement.
- After the initial term, both parties have agreed to assess opportunities to expand the product line to include the SteriLumen platform of connected UVC devices for infection control.
- The Airocide System is an airborne pathogen-killing technology that uses a patented combination of UVC and a proprietary titanium dioxide-based photocatalyst.
- Price Action: AUVI shares are up 0.41% at $7.35 during the market session on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
